EVENTS

Interdisciplinary & Collaborative Research Panel

Format: The panel will be a moderated discussion in a Q&A format. Panelists do not need to formally present any materials or plan formal remarks.

Moderator:  Geoff Abbott, Professor, Physiology & Biophysics Vice Dean, Basic Science Research, School of Medicine

Panelists:

• Aileen Anderson,  Director, Sue & Bill Gross Stem Cell Research Institute; Professor, Physical Medicine & Rehabilitation, School of Medicine
• Scott Bartell, Associate Dean of Academic Affairs; Professor, Environmental and Occupational Health, Program in Public Health; Professor, Statistics
• Alexandre Chan, Professor of Clinical Pharmacy and Founding Chair, Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences
• Krzysztof Palczewski, Irving H. Leopold Chair of Ophthalmology, Distinguished Professor, School of Medicine
• Amir Rahmani, Professor, Sue & Bill Gross School of Nursing; Professor of Computer Science; Associate Director, Institute for Future Health
• Richard Van Etten, Director, Chao Family Comprehensive Cancer Center; Professor, Division of Hematology/Oncology, Biological Chemistry, School of Medicine
• Xiangmin Xu, Professor, Anatomy and Neurobiology; Director, Center for Neural Circuit Mapping, School of Medicine

Potential Questions:

• Collaboration extends beyond UCI, how can we collaborate with healthcare practitioners, policymakers, patients, and industry partners to create a holistic approach to healthcare research and innovation?

• How do you envision the future of interdisciplinary translational research? What emerging trends or technology are likely to further drive collaboration and innovation?

• How do we create incentives to work in cross-disciplinary teams?

• How do we evaluate the value added of team science, in general, but also specifically in the context of a new building bringing many disciplines together? In such a building, how do we handle the logistics of teams and priorities changing over time? How do we incentivize schools and depts to look beyond those traditional silos?

• In what ways can interdisciplinary research positively impact patient care, treatment strategies, and overall healthcare outcomes, any examples?

• How might the new FLFMIB encourage the formation of new research teams and projects that transcend traditional disciplinary boundaries in healthcare?